Uxin Limited (NASDAQ:UXIN) does about 1.18M shares in volume on a normal day but saw 6669354 shares change hands in Monday trading. The company now has a market cap of 254.05M USD and an enterprise value of about $614.60M. Its current market price is $0.78, marking a decrease of -14.29% compared to the previous close of $0.91. The 52 week high reached by this stock is $3.80 whilst the lowest price level in 52 weeks is $0.88. The script in recent trading has seen the stock touch a high of $0.9599 and a low of $0.72.
Uxin Limited (UXIN) has a 20-day trading average at $1.1590 and the current price is -79.47% off the 52-week high compared with -11.36% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.3550 and its 200-day simple moving average is $1.8061. If we look at the stock’s price movements over the week, volatility stands at 15.70%, which decreases to 6.73% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 16.88 to suggest the stock is oversold.
1 analysts observing the Uxin Limited (UXIN) stock have set the 12-month price targets for the company’s shares at between $32.14 and $32.14. The median price target is 97.57% away from the current levels at $32.14.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 23, 2019 when JP Morgan downgraded the stock to “Neutral” and issued a price target of .
The current price level is -33.98%, -43.00%, and -57.03% away from its SMA20, SMA50, and SMA200 respectively, with the UXIN price moving above the 50-day SMA on August 31. Uxin Limited (UXIN) stock is down -33.90% over the week and -38.58% over the past month. Its price is -65.49% year-to-date and -71.43% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/30/2020, with the company’s earnings per share (EPS) of -$0.03 above consensus estimates by $0.08. The company’s next earnings report is expected on 11/24/2020, with forecasts estimating quarterly EPS at -$0.09 and $0 for whole year.
Its 12-month price target is $32.14. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $32.14, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $32.14.
Outstanding shares total 296.15M with insiders holding 0.00% of the shares and institutional holders owning 27.82% of the company’s common stock. The company has a return on investment of -44.70%. Price to sales ratio is 1.34.
According to a U.S. Securities and Exchange Commission filing, Wells Fargo Emerging Markets Equi has reduced its position in Uxin Limited (UXIN) to 3,950,000 shares, mirroring a recent drop by 0.00%. Wells Fargo Emerging Markets Equi dumped 0.0 shares of Uxin Limited common stock bringing its total worth to about $5.02 million at the end of recent close, SEC documents show. Wells Fargo Emerging Markets Equi isn’t the only investment manager who changed stakes and is followed by Baillie Gifford Overseas Growth F, which sold off 0.0 shares to end up with 1,211,500 shares worth $1.54 million. iShares Core MSCI Emerging Market raise their holdings by 1.11% in the company over the course of the most recent quarter. It now holds a 0.33% position in Uxin Limited thanks to 0.93 million shares amounting to $1.18 million.